http://www.frost.com/prod/servlet/svcg.pag/HC00 http://www.frost.com/prod/servlet/svcg.pag/HC00 - Healthcare Research Frost & Sullivan http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D744-00-A1-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D744-00-A1-00-00

This week's issue of Advanced Coatings and Surface Technology Alert focuses on innovative stent coating materials for better control and delivery of gene therapy, advances in suspension plasma sprayed titanium oxide coatings, description of surface topography with fractal and prolifometric methods, an affective approach to grow epitaxial graphene by using a carbon implant on silicon substrate, and synthesis of thin-multiwalled carbon nanotubes and characterization of field emission properties.

Fri, 9 May 2008 23:41:37 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0E-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0E-00-00

This week's issue of Drug Discovery Technology Alert profiles articles on a novel technology for drug formulation and oral drug delivery, a method to determine phosphorylation signatures, drugs that potentially prevent heart disease in kidney patients, vaccines to treat Alzheimer's Disease, a screenign tool with exceptional HTS and HCS capabilities, a novel anti-biofilm compound as an alternative to antibiotic therapy, MicroRNA antagonists as promising agents for Hepatitis C treatment and novel small molecules drugs capable of hindering the Aurora/Centrosome cancer pathway.

Fri, 9 May 2008 23:41:37 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-61-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-61-00-00

This week's issue of Nutrition Alert profiles articles on recent findings pertaining to diets, soy protein, whey protein, MCTs, artificial sweetener, dietary fiber, fat soluble vitamins, mineral sources, foods affecting cholesterol and glucose levels, specialized formulas and supplements, weight loss therapy, and obesity.

Fri, 9 May 2008 23:35:38 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6F-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6F-00-00

This week's edition of Medical Device Technology Alert features articles on 3D matrix aimed at cartilage regeneration, cooling system for victims of sudden cardiac arrest, portable noninvasive brain monitoring device, nonlinear cardiovascular system model for real-time therapy assistance, mechanical testing of a single polymeric nanofiber, enhanced performance of undulation type artificial heart, laser-assisted cosmetic surgery for fat cell removal, and NIRS for variegated medical applications.

Fri, 9 May 2008 01:08:38 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-9A-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-9A-00-00

This week's issue of Industrial Bioprocessing Alert profiles the development of starch-based biosustainable plastics; a polymer-based technology platform aiding in effective delivery of therapeutics and vaccines; ready made mini chromatography columns, which enable multiplexing of protein seperation; research findings enabling the removal of free fatty acids using zeolite catalysts; and finally analyst insights figuring out the strengths and success factors behind biofuels. Key patents from the bioprocess industry are also included.

Fri, 9 May 2008 01:02:40 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-9B-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-9B-00-00

This week's issue of GTN Alerts profiles the novel discovery of a gene, which can reverse angiogenesis and thus fight cancer; research findings aimed at retinal degeneration; dendrimers nanotechnology-based platform targeting treatment for life-threatening diseases; research findings highlighting gene therapeutic approach for spinal muscular atrophy; microRNAs emerging as lung cancer therapeutics; breakthrough studies generating cancer stem cells from embryonic stem cells source. This alert also highlights few prominent strategic partnerships and includes a coverage on key patents.

Fri, 9 May 2008 00:57:38 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=129441437 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=129441437

Europe, in the recent years has observed an enormous growth in the occurrence of cardiovascular diseases. It is estimated that such disorders are responsible for 4 million deaths in Europe every year. This rapidly growing healthcare problem has however spurred greater initiatives amongst healthcare professionals as well as vendors worldwide to develop better technologies and clinical diagnostic tools to fight the disorders. The fierce competition amongst the vendors has given a huge boost to the technology development cycle of most products pertaining to the European medical imaging modalities for cardiology applications.

Fri, 9 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=129500036 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=129500036

In Union Budget 2008-2009, the health sector received significant attention, and was mentioned as one of the pillars of social reform. This article evaluates the effectiveness of the government's health improvement initiatives in Union budget 2008-2009.

Fri, 9 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-99-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-99-00-00

Greenline Industries have made use of Amberlite BDIODRY technology developed by Rohm and Haas, to come out with waterless biodiesel manufacturing technology. PetroSun has been considering using microalgae as a source for producing biofuel and is planning to produce an estimated 4.4 million gallons of algal oil and 110 million lbs.of biomass per year off a series of saltwater ponds that span 1,100 acres. BioChemics Inc. based at Danvers, Massachusetts, has pioneered a novel drug delivery technology based on microencapsulation thus enabling an efficient transdermal delivery of a wide variety of pharmaceutical drugs in the market.

Fri, 2 May 2008 06:07:24 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-9A-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-9A-00-00

This week's issue of GTN Alert profiles articles on usage of zebrafish models for identification of potential drug candidates; promising gene therapy involving research findings, which could be eventually translated into addiction therapies; research findings highlighting the fact that vectors could deliver successful treatments; university studies focused on creating synthetic cells; nanotech-based system for genetic analysis; technology platform offering unique means of DNA isolation as well as effective means of detecting gene variations; and analyst perspectives on speculation surrounding the requirement of HPV vaccine mandate. The alert also delivers a snapshot of strategic partnerships and key patents.

Fri, 2 May 2008 05:25:22 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D833-00-88-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D833-00-88-00-00

The current issue of Future Tech alert provides information on recent developments and futuristic overview of smart polymers used for biomedical applications that may impact the healthcare industry. It also analyzes the key innovations, trends, and relevant patents in this arena.

Fri, 2 May 2008 03:18:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128837508 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128837508

Patient adherence is a continuing concern for the medical community and the drug industry. The following presentation is from the 3rd Annual Frost & Sullivan Executive Congress Committing to the Patient: Personalized Interventions that Drive Improved Adherence. Discussed are points including barriers to adherence, how these can be addressed, strategies to increase the flow of information, best practices in adherence programs, and solutions for improved adherence.

Thu, 1 May 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M113-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M113-01-00-00-00

This research examines the clinical information systems-oncology markets in Europe in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts and growth rates and strategic recommendations.

Wed, 30 Apr 2008 11:43:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128772297 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128772297

Noninvasive Glucose Monitoring: The Elusive Goose

Tue, 29 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R2DE-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R2DE-01-00-00-00

Frost & Sullivan Awards are presented to companies that have exhibited excellence within their industry. This deliverable presents the Frost & Sullivan Awards for the U.S. Smoking Cessation Drug Market (N2DE-52).

Mon, 28 Apr 2008 11:21:28 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128762456 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128762456

East African Infectious Diseases Diagnostics Market

Mon, 28 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R30B-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=R30B-01-00-00-00

Frost & Sullivan Awards are presented to companies that have exhibited excellence within their industry. This deliverable presents the Frost & Sullivan Awards for the U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook (N30B-52).

Fri, 25 Apr 2008 10:31:34 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6E-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6E-00-00

This week's edition of Medical Device Technology Alert features articles on a clinical system for anaesthesia, a ventricular assist device, an implantable device for tracking tumors and fising radiation dose, a peripheral artery bypass graft, inner ear implant, bioartificial pancreas, a nanotech-based device for drug delivery, and nanotube sensors to monitor insulin levels.

Fri, 25 Apr 2008 04:49:35 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-98-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-98-00-00

This week's issue of GTN Alert profiles articles on a technology platform employing genetic chemistry for cost-effective drug development, spinal muscular atrophy treatment enabled through targeted gene alteration method, RNAi technology utilized for the production of human therapeutic glycoproteins, biomarkers for assessment of cancer therapy outcome, a novel gene sequencing technique enabling researchers to obtain sequence information from single molecules of DNA devoid of gene amplification, novel gene shuffling technique for production of optimized proteins, and an innovative magnetic targeting approach to effectively target tumors.The alert also provides insights into important strategic partnerships as well as important patents.

Fri, 25 Apr 2008 04:39:34 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-98-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-98-00-00

This week's alert features the world's first commercially viable cellulosic ethanol plant and a plant system for high-quality human collagen production. In addition, protein engineering technologies for production of functionally optimized biotherapeutics, and some important patents have been featured.

Fri, 25 Apr 2008 04:39:34 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128469447 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128469447

A Laboratory Information System (LIS) is a software module in a hospital laboratory which serves to operate and manage all types of clinical test activities and store the test results in its database. This module comprises of a database manager, programming language, hardware, and operating systems. It supports clinical tests for hematology, endocrinology, immunology, cytology, microbiology, and other specialized test.

Thu, 24 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128402711 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128402711

Bone growth and spinal fusion stimulation applies electromagnetic energy to a fracture or fusion site in order to encourage and/or accelerate bone growth and bone healing. In the event of bone fractures and damage, growth factors released at the site of injury begin the healing process by stimulating osteoblasts, fibroblasts, endothelial, and other specialized cells to in order to restore tissue to its original strength and shape. Bone generates its own piezoelectric current, and once bone has been traumatized, it responds positively when electromagnetic energy is applied to it in order to speed up the healing process.

Wed, 23 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128459886 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128459886

European Mass Spectrometry Market

Wed, 23 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128459931 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128459931

European Ultrasound Market

Wed, 23 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1C3-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1C3-01-00-00-00

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, restraints, competitive structure, strategic recommendations and list of market participants.

Tue, 22 Apr 2008 07:02:39 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128394679 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128394679

Metabolomics can be defined as the sequential study of the unique chemical fingerprints that are visualised and left during any cellular process. This area of science primarily involves the study of metabolic profiles and their comparative analysis. These profiles are a part of a larger entity known as the metabolome. The complexities concerning metabolite profiling involve the analysis of all classes of compounds found in a tissue or cell and not just a single entity such as proteins or DNA. Hence devising a standardised protocol for analysing various metabolites requires robust analysis platforms.

Tue, 22 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128394740 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128394740

Declining productivity and thinning R&D pipeline despite high R&D intensity is probably the most oft repeated phrase used to characterise the current research based pharmaceutical industry.

Tue, 22 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0F6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0F6-01-00-00-00

This segment contains the awards for the mobility aids markets in Europe, 2008.

Sat, 19 Apr 2008 03:05:35 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128138959 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128138959

Michael Faraday first used the word electrode, which was derived from elektron a Greek word. In electronic circuits electrons serve the purpose of hording or discharging electrical charge through a circuit. In medicine, the physiological signals in the human body are captured using various kinds of electrodes. This technique is termed electrophysiology. To detect the potential change in the different organs of the body and monitor their activity the study of physiological signal is instrumental. For the heart, study carried out is termed Electrocardiography (ECG).

Sat, 19 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128139041 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=128139041

Adapt and Defend: Strategies to Sustain the ELISA Market in Face of Multiplex Shift

Sat, 19 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N36A-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N36A-01-00-00-00

This research service provides an in-depth analysis of the U.S. clinical trial management systems market. The research service includes revenue forecasts, data management needs analysis, vendor analysis, market drivers and challenges.

Fri, 18 Apr 2008 15:44:35 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0D-00-00

This week's issue of Drug Discovery Technology Alert profiles articles on isobaric mass tags that enhance accuracy and reproducibility of proteomic experiments, a unique method of cell-free gene expression, microfluidic chip-based technology for cell-based assys for drug discovery, a virtual method of drug screening for drug discovery, aptamer-based biomarker discovery technique, a novel screening technique that enhances fragment-based drug discovery, microfluidic technology to study platelet aggregation, and combination therapy for prostrate cancer.

Fri, 18 Apr 2008 06:44:40 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-97-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-97-00-00

This week's issue of GTN Alert profiles articles on novel therapeutic potential of epigenetic targets, a chemically linked immunogenic peptides on scaffolds technology platform for generating functional antibodies,findings of bacteria that consume both natural as well as synthetic antibiotic compounds, promising therapeutic targets for GERD disease utilizing allosteric modulation mechanism, research findings highlighting mother precursor cells to dopaminergic neurons found in early brain development stages, study findings indicating that molecular changes in the brain are clearly reflected by presence of biomarkers, easy to administer single dose typhoid vaccine and data analysis software for pyrosequencing of DNA.

Fri, 18 Apr 2008 04:45:41 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-2E-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-2E-00-00

This week's edition of Medical Diagnostic Imaging Technology features articles that include quantification of mitral regurgitation,graphical user interface for intelligent analysis, detection of frost bite in biological tissues, an image analysis technology that facilitates better diagnosis, a novel cancer detection device, a non-invasive technique to assess bone strength and quality, a device that tackles the shortcomings of fluorescent imaging, a mechanical imaging system for diagnosing prostate cancer and a device that is positioned as an effective substitution for the painful processes involved in cervical examination

Fri, 18 Apr 2008 04:39:41 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D784-00-99-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D784-00-99-00-00

Fuzzy-Logic Delivery Systems--Functionalized solid lipid nanoparticles with complex surface chemistry are a big step in creating smart imaging and therapeutic agents for treatments for cancers. Semitransparent conductive coatings with tunable optical transmittance can be produced using metallic SWNTs. A new technique creates nanodroplet test tube' for studying individual proteins. A nanomotor uses a thermal gradient to move and rotate cargo from one end of a CNT to the other. EU project will look fostering dialogue on nanotech opportunities and risks in Europe.

Fri, 18 Apr 2008 04:33:41 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q19E-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q19E-01-00-00-00

This research service provides the description of the best practices awards for the recipients in the European obesity surgery devices market.

Tue, 15 Apr 2008 05:21:43 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N369-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N369-01-00-00-00

The U.S. Non-Infectious Disease Vaccine Pipeline research service contains an overview of the vaccine pipeline and development information for non-infectious diseases (Oncology, Cardiovascular, Multiple Sclerosis, Addiction Disorders). The research service also provides an overview of vaccine development, major challenges, and conclusions.

Fri, 11 Apr 2008 10:38:22 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-96-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D764-00-96-00-00

Xenome has a unique proprietary library of venom peptides that can be translated into robust libraries of biomolecules. A study at the University of Nebraska, Lincoln (UNL) elaborates on the potential of switchgrass as a biomass fuel. In an effort to bring attention to other crops aside from tomatoes that are high in lycopene, researchers from the Department of Biological and Agricultural Engineering at the University of Arkansas have carried out lycopene extraction studies on watermelons.

Fri, 11 Apr 2008 07:12:23 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6D-00-00

This week's edition of Medical Device Technology Alert features articles on treatment of motor diseases, epileptic seizure alarm, microfluidic chip based on femtosecond lasers, a prescreening tool for sleep apnea, cardiac surgery performed using robots, automatic wheelchairs using EMG signals, mitral valve stimulators, and a bioabsorbable plaque for effective closure of arterial puncture.

Fri, 11 Apr 2008 05:57:22 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-60-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D813-00-60-00-00

Fri, 11 Apr 2008 05:52:22 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-96-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-96-00-00

This week's issue of Genetic Technology Alert profiles articles on a technology platform for DNA methylation, herbal dietary supplement to aid in neurological functions, quantification of amyloid beta peptides, molecular mechanism against tuberculosis bacterium, altered polyketides, short hairpin RNAs, a novel recombinant protein production technology, and discovery of viral gene that causes obesity. The alert also provides important patents.

Fri, 11 Apr 2008 05:42:24 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M19E-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M19E-01-00-00-00

This research service examines the European obesity surgery devices markets in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts,growth rates and strategic recommendations.

Thu, 10 Apr 2008 07:01:42 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1B7-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1B7-01-00-00-00

This research study addresses the latest issues and market dynamics in the U.S. closed loop medication management market. It contains major drivers, restraints, challenges and strategies, revenue forecasts, select competitive profiles, market trends, market analysis, workflow requirements, technologies, and scenario analysis.

Wed, 9 Apr 2008 11:11:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1A6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1A6-01-00-00-00

Research was carried out to investigate the scope and scale, as well as growth prospects for the South African patient monitoring sector. A thorough PESTLE (political, economic, social, technology, legal and environmental) analysis was established for South Africa allowing for an accurate evaluation of the external factors impacting the healthcare industries. Market sizes for the patient monitoring sectors were calculated for 2006 and forecasts determined for the period 2006 to 2012. In addition, market dynamics, such as challenges, drivers and restraints, were also identified.

Wed, 9 Apr 2008 06:13:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127120034 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127120034

Brazil is currently going through a period of economic prosperity, with constant GDP and per capita income growth. This favorable scenario is likely to be sustained over the next years.

Wed, 9 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M18A-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M18A-01-00-00-00

This research service gives detailed view of European E-Clinical Trials Market.

Tue, 8 Apr 2008 22:04:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F6-01-00-00-00

Research was carried out on the hypertension market in the Kenyan healthcare industry. A thorough PESTLE (political, economic, social, technology, legislation, and environmental) analysis was established for Kenya. Market sizes for the hypertension pharmaceutical sector was calculated for 2006 and forecasts were determined for the period 2006-2012. In addition, the market dynamics such as the industry challenges, market drivers, and market restraints were identified.

Tue, 8 Apr 2008 07:24:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F7-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F7-01-00-00-00

Research was carried out on the Diabetes Market in the South African Healthcare Industry. A thorough PESTLE (political, economic, social, technology, legislation, and environmental) analysis was established for South Africa. Market sizes for both the insulin and oral anti-diabetic drugs sectors were calculated for 2006 and forecasts were determined for the period 2006-2012. In addition, the market dynamics such as the industry challenges, market drivers, and market restraints were identified.

Tue, 8 Apr 2008 07:13:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F8-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1F8-01-00-00-00

Research was carried out on the Diabetes Market in the Kenyan Healthcare Industry. A thorough PESTLE (political, economic, social, technology, legislation, and environmental) analysis was established for Kenya. Market sizes for both the insulin and oral anti-diabetic drugs sectors were calculated for 2006 and forecasts were determined for the period 2006-2012. In addition, the market dynamics such as the industry challenges, market drivers, and market restraints were identified.

Tue, 8 Apr 2008 07:08:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=BA0A-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=BA0A-01-00-00-00

This research service seeks to forecast the heart valve repairs market in Europe. It gives an insight into the market drivers, restraints and challenges facing the market. It also provides strategic recommendations and forecasts the market till 2014 for three segments of the implant market that include the mechanical valves,tissue valves and annuloplasty rings. It also discusses percutaneous heart valve technology(PVHT).

Tue, 8 Apr 2008 01:22:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127102083 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127102083

According to a study conducted by New York University researchers, U.S. Pharmaceutical Companies are spending almost twice as much on advertising as on research and development. This study called The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States was published in the January 3, 2008 issue of PLoS Medicine. It analyzed data collected from two sources and concluded that the U.S. pharmaceutical industry spent 24.4 percent of the money earned in sales on promotion and only 13.4 percent for research and development. This study authored by PhD candidate Marc-Andre Gagnon and Dr. Joel Lexchin, examined data collected from 2004 reports from IMS Health and CAM Group. From these, they were able to get sales and marketing data for the pharmaceutical industry. It was noted by the authors that the numbers from IMS Health and CAM Group did not agree. This was attributed to the different sources of information for both sources as IMS Health gets its information directly from the Pharmaceutical companies while CAM Group gets their information from doctors. According to CAM Group, $33.5 billion was spent by the pharmaceutical industry for total promotion spending compared to the $27.7 billion reported by IMS Health. The authors combined select information obtained from both sources and deduced that the total promotion spending in 2004 was $57.5 billion.

Tue, 8 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127102252 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=127102252

On March 13, 2008, a new bill was introduced into the House that would create a way for the FDA approval of biogenerics. H.R. 5629 is a bipartisan bill called the Pathways for Biosimilars Act. This bill was introduced by Representatives Anna Eshoo (Democrat, California) and Joe Barton (Republican, Texas). This bill provides a way for biosimilars to be approved by referencing an approved biological product. As part of the application process, the applicant must submit results from studies that show that their biological product is in fact highly similar to the referenced approved product. Not only does this bill offer a pathway for the approval of biosimilars, but it also provides for 12 years of exclusivity to the first product licensed (reference product). In addition, this exclusivity can be extended to two years for medically significant new indications and for an additional six months for approvals in the pediatric population. For conventional medications there are standards in place for the approval of generic compounds, mainly the Hatch-Waxman act. However for biologics there are no set regulatory standards. In addition, biologics are approved following the filing of a Biologics Licensing Application (BLA) as opposed to a New Drugs Application (NDA). This puts monoclonal antibodies under the Public Health Services Act which makes them ineligible for approval under the Hatch-Waxman act.

Tue, 8 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1EB-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1EB-01-00-00-00

This research service examines the eastern European advanced wound management market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the revenue forecasts, growth rates, and strategic recommendations.

Mon, 7 Apr 2008 06:41:24 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M0F6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M0F6-01-00-00-00

This research service examines the European mobility aids markets in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets, the revenue forecasts, growth rates, as well as strategies to be utilised.

Mon, 7 Apr 2008 06:24:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1E2-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1E2-01-00-00-00

This research service explores the market for therapeutics that are developed for the treatment of Fibromyalgia Syndrome in Europe. It analyses the various challenges faced by the pharmaceutical companies and the competitive advantage of their products in the market.

Mon, 7 Apr 2008 06:18:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126906113 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126906113

The Wireless Medical Telemetry Patient Monitoring is Evolving and Expanding Rapidly. Both the Strategic Partnerships and Innovations will lead the Direction of this market

Mon, 7 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126965261 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126965261

E-Clinical Technologies: Market Growth

Mon, 7 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-95-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-95-00-00

This week's issue of Genetic Technology Alert profiles articles on a novel tool for immediate visualization of proteins during the course of protein production in Escherichia coli and protein purification, a novel class of anticancer drugs that primarily disrupt tumor vasculature, angiogenic cell precursor-based technology platform for heart disease treatment, resistance mechanism of Methicillin-resistant Staphylococcus aureus (MRSA) to natural defenses, a breakthrough technology for DNA engineering, discovery of gene behing amyotropic lateral sclerosis (ALS), study that reveals the role of rare gene mutatiosn in schizophrenia and mutated HIV vaccine strategy. The alert also covers important patents and strategic partners.

Fri, 4 Apr 2008 03:08:23 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0CE-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0CE-01-00-00-00

The research service provides a detailed description of the award presented to Heal Force Biomeditech Holdings. The award has been conferred to the company for exhibiting entrepreneurial abilities in the market. It further describes the criteria to be fulfilled and the methodology involved in nominating the company for the award.

Thu, 3 Apr 2008 05:14:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P13D-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=P13D-01-00-00-00

This research services emphasizes Malaysia pharmaceutical industry and its potential to move forward with the global changes. The research service first review the global pharmaceutical industry and the shifting trend that influence the growth and performance of other regions including Malaysia. This will then lead the readers to explore the current trend and market landscape of Malaysia industry. Through out this research services, readers will get the information on how Malaysia performed in both healthcare and pharmaceutical industry and what are the prospects that Malaysia can offer to local and international pharmaceutical companies as well as the contract research organisations.

Thu, 3 Apr 2008 05:03:22 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126368892 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126368892

The global economic canvas is currently faced with several challenges

Wed, 2 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126369590 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126369590

This market insight aims to provide an overview of the Malaysian pharmaceutical industry in terms of the factors that drive and restrain the market, sales trends, government initiatives, and potential growth and market opportunities. At the outset, a brief discussion on the global pharmaceutical industry is also provided, in order to highlight the trends that have resulted in a shift of global pharmaceutical trend away from the West to Asia, including Malaysia.

Wed, 2 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126405293 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126405293

Drug Delivery - Assessing Market and End User Opportunities for Product Design

Wed, 2 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126182481 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126182481

Today, healthcare executives are under tremendous pressure to address a host of different challenges: medical errors, rising costs, inconsistent quality, inefficiency, declining doctor satisfaction, and mounting staff shortages. Dealing with these issues will ultimately lead to better healthcare, but the process appears as complex and overwhelming as the challenges themselves. Information or lack of it is a big part of today's healthcare problems.

Tue, 1 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126182600 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126182600

Movers & Shakers Interview with Martin T rnvik, Vice President Sales and Global Marketing, Ziehm Imaging GmbH

Tue, 1 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126245706 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126245706

Strategic Outlook of the European Pharma/Biotech Contract Manufacturing Markets

Tue, 1 Apr 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10D-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10D-01-00-00-00

This research service outlines the key developments taking place globally and emerging trends in the field of noninvasive technologies for glucose monitoring.

Mon, 31 Mar 2008 22:34:24 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N2D4-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N2D4-01-00-00-00

This study analyzes major market trends, forecasts future changes in market measurements, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges for the North American Fluoroscopy (R/F) and Mobile C-arm Market. The major geographic division covered is North America (including the United States and Canada).

Mon, 31 Mar 2008 15:25:23 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=DD27-00-03-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=DD27-00-03-00-00

Mon, 31 Mar 2008 05:53:40 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M116-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M116-01-00-00-00

This research service provides an insight into the key programmes supporting healthcare IT in Europe

Mon, 31 Mar 2008 04:44:16 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10F-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10F-01-00-00-00

A detailed assessment of the emerging trends and innovations in the field of physical rehabilitation.

Mon, 31 Mar 2008 03:40:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10B-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D10B-01-00-00-00

This research piece on contrast agents provides the reader with a complete picture of the trends that relate to the contrast agent business.

Mon, 31 Mar 2008 03:19:22 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D0FD-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D0FD-01-00-00-00

This research service provides the latest trends in apoptosis research and future developments

Mon, 31 Mar 2008 01:24:23 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126134255 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126134255

Stem cells can be considered the basis for every organ, tissue and cell within the human body, and are classified into two distinct types: adult stem cells and embryonic stem cells. While the first ones are derived from developed organs or tissues, such as the bone marrow or the cord blood of newborns' umbilical cords, the second ones are obtained from embryos resulted by in vitro fertilization.

Mon, 31 Mar 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126134723 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=126134723

Movers & Shakers Interview with Andrea Carabelli, Regional General Business Manager Healthcare Information Solutions for Latin America, Carestream Health, Inc.

Mon, 31 Mar 2008 00:00:00 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D103-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D103-01-00-00-00

This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective.

Sun, 30 Mar 2008 23:31:24 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D114-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D114-01-00-00-00

This research service outlines the key global developments in cardiovascular drug therapies.

Sun, 30 Mar 2008 23:27:04 +0100 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D0FE-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=D0FE-01-00-00-00

This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.

Sun, 30 Mar 2008 23:22:53 +0100 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6C-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6C-00-00

This week's edition of Medical Device Technology Alert features articles on home-based diagnostic system for obstructive sleep apnea, noninvasive cryoanesthetic device for drug free pain relief, anatomically designed orthopedic implant for wrist fracture, robotic arm for surgical navigation, noninvasive diagnostic device for early detection of breast cancers, a device for determining the airway inflammatory status, advanced materials for implants, and nanopolymeric materials for effective wound dressing.

Fri, 28 Mar 2008 05:31:18 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-94-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-94-00-00

Genentech has chosen an inhibitor of MEK, a member of the MAP pathway, from Exelixis to further develop for treating cancer. Pending final analysis of completed animal toxicology studies NIH and Avicena are ready to start clinical testing of Avicena's lead product candidate, designed to slow the progress of Huntington's disease. VistaGen has formed an alliance with University Health Network to carry out research into advanced techniques to differentiate embryonic stem cells into mature cardiac, liver, and pancreatic beta-islet cells. Centocor and Schering Plough have applied to European regulatory authorities to market golimumab for treating three different autoimmune diseases.

Fri, 28 Mar 2008 03:44:17 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125782708 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125782708

It is widely documented that the health care industry has been slow in the adoption of IT and is well behind other industries, such as financial services and telecommunications. The lower level of IT investment and automation has resulted in an industry that continues to rely heavily on paper and manual processes. This lack of automation is seen as one of the key reasons for the increasing inefficiency and quality problems.

Fri, 28 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125783582 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125783582

Statistical data suggest that today, there are about 150,000 new cancer cases detected in Mexico each year. In comparison with other developed regions such as in United States (U.S.) and the European Union (E.U.) , cancer incidence in Mexico does not seem to be a major concern for Health Authorities. However this does not reflect reality, as Mexico's cancer incidence rates are somehow distorted and do not reflect the dramatic increase of this disease in the Mexican population.

Fri, 28 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M20E-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M20E-01-00-00-00

This research service give a detailed analysis of the European LIMS market from 2007 to 2014. The effect of various drivers and challenges for the LIMS market are discussed and revenue forecasts provided based on market dynamics. Customer requirements and technology trends are also discussed. The segmentation include LIMS application for pharmaceutical R&D, manufacturing and clinical trials data management. Strategic recommendations are provided for the various challenges facing LIMS vendors in the European market.

Thu, 27 Mar 2008 05:16:17 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125640557 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125640557

The proliferation of composite materials on the market has been confusing for the practicing dentist. However, in spite of the large number of dental composite products that have appeared during the past 15 years, they all have simple, common characteristics. They were first put to widespread use by dentists in 1960's but the composite materials in that era were relatively of poor strength and wear properties.

Thu, 27 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125641003 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125641003

The most recent step up until this article's writing - towards its governmental implementation in Argentina has been the presentation of a law project to the National Congress in June 2007, which promotes the creation of a National Health Technology Assessment Agency within the scope of the National Ministry of Health.

Thu, 27 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125642515 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125642515

The tobacco industry, in Mexico is being threatened by new regulations and medical options with the only objective of benefiting Mexicans health.

Thu, 27 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125523706 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125523706

The healthcare industry can be considered one of the most vibrant and complex economic sectors in the world. The healthcare landscape is in a continuous state of dynamic evolution, with staggering amounts of information - physical and electronic - generated from healthcare organizations, every day. This has put healthcare organizations under tremendous pressure to be more efficient and cost effective.

Wed, 26 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125585641 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125585641

Obesity in Europe - Is Surgery Gaining Momentum and Driving Market Growth?

Wed, 26 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125518773 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125518773

The Closed Loop Medication Market

Tue, 25 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N220-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N220-01-00-00-00

Frost & Sullivan's medical devices Financial Benchmarking and Analysis (FBA) service presents a financial outlook of the U.S. medical devices industry, highlighting major market and financial trends in select growth segments. The FBA focuses on the fourteen segments of the U.S. medical devices industry, namely: cardiovascular devices, orthopedic devices, general surgery, endoscopy, neurology devices, urology and gynecology, ophthalmic equipment, cosmetics and aesthetics, hearing and audiology, wound care and management, respiratory and anesthesia equipment, disinfection and sterilization, infusion systems and mobility aids.

Mon, 24 Mar 2008 02:20:54 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-2D-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D860-00-2D-00-00

This week's edition of MDIT Alert features articles on tissue imaging system with fluorescent and bright field imaging capabilities, advanced genetic analysis tools for cancer detection, targeted PET for early diagnosis of brain dysfunction, light-powered platinum complex with anticancer activity, interactive medical image analysis software, robotic platform integrated with imaging for screening applications, three dimensional cardiac imaging system, a novel three dimensional (3D) image reconstruction technique from two dimensional (2D) image data from patient-specific bone models, contrast agents for microCT applications, and harmonic holography.

Fri, 21 Mar 2008 22:49:17 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D774-00-96-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D774-00-96-00-00

In this issue, we look at advances in neural control of electronics, a material that could form an invisibility cloak' for magnetic fields, advances in quantum information research, investigations into the security of implanted medical electronic devices, and using carbon nanotubes as interconnect elements.

Fri, 21 Mar 2008 22:43:19 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-93-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-93-00-00

Sitris has obtained rights to technology for introducing the NamPRT gene into aging human vascular smooth muscle cells to delay their deterioration. KaloBios is developing a monoclonal antibody against granular macrophage colony-stimulating factor (GM-CSF) to treat inflammation associated with asthma. Cardium's gene therapy prevents reperfusion injury in heart attack patients. Curis looking for a new partner for hedgehog pathway protein agonists for treating stroke after Wyeth discontinued its collaboration. AlphaMed has successfully expressed a glycosylated human version of alpha 1-antitrypsin (AAT) in yeast. Applied Biosystems has brought the cost of sequencing a complete human genome down to $60,000.

Fri, 21 Mar 2008 22:37:18 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1A6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1A6-01-00-00-00

This research service studies the obesity surgery devices market in the United States. The market is segmented as adjustable gastric banding devices, gastric bypass devices, vertical banded gastroplasty devices, intragastric balloon devices and emerging technologies. It covers the market from the aspects of the driving forces, restraints and challenges, also providing strategic recommendations. Revenue and procedures analysis is provided in the study for a forecast period of 2007-2013. Market share and competitor structure of the market is also discussed.

Fri, 21 Mar 2008 14:28:24 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=AA63-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=AA63-01-00-00-00

This award deliverable presents the Frost & Sullivan Awards for Best Practices in the North American multiparameter patient monitoring markets (study code F847).

Fri, 21 Mar 2008 10:23:17 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N133-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N133-01-00-00-00

This research service analyzes the market for cell-based assays within the United States. This market was divided into three segments, covering cell growth-associated assays, cell death-associated assays, and functional cell assays. Each segment of this service provides an overview, analysis of products available, revenue forecasts, and market share analysis. Key challenges and strategies are covered for the total market, as are market drivers and restraints. This study presents information on key research and drug discovery applications expected to influence the market, and highlights recent developments and product features that should be emulated by market participants to achieve corporate growth objectives.

Fri, 21 Mar 2008 09:06:17 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N155-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N155-01-00-00-00

This research service analyzes the market for hematology test products and services within the United States.

Thu, 20 Mar 2008 15:47:16 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1B8-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M1B8-01-00-00-00

This research service examines the European market for bone grafts and bone cements in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure in the major markets, the revenue forecasts, growth rates, as well as strategies to be utilized.

Thu, 20 Mar 2008 05:31:17 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0CC-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=Q0CC-01-00-00-00

Frost & Sullivan Awards are presented to companies that have exhibited excellence within their industry. This deliverable presents the Frost & Sullivan Awards for the Eastern European Temperature Monitoring Devices Market.

Thu, 20 Mar 2008 02:53:19 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124964830 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124964830

Over the years pharmaceutical companies are facing an increasing number of challenges such as higher costs, competition from generics, and lack of productivity from R&D. The stakes are extremely high in a trial as it is very important to be able to patent a drug and its process while being the first to launch it in the market. Pharmaceutical companies spend at least 10 percent of their operating budgets on clinical trials, so it is important to make the process faster and more efficient so as to maximise profits amidst stiff competition and stringent regulatory environments.

Thu, 20 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124965013 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124965013

The pharmaceutical industry is in an era when it has reached the crossroads, facing multiple challenges. The industry is plagued by the need to reduce timescales for new drug discovery, shrinking profit margins, supply chain pressures and changing regulatory requirements, while more and more drugs go off-patent. Amidst all these issues pharmaceutical companies need to sustain valuable growth in highly competitive markets and these challenges have clearly not de-motivated them from launching new products in the market.

Thu, 20 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125034743 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=125034743

Every POC vendor has drawn his own specifications to develop a POCT instrument and there seemed to be no issues in the market with respect to the individuality of these instruments.

Thu, 20 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124860482 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124860482

Heart Disease in Europe has exacted a heavy price out of Europe both financially and socially. The health bodies of the different European countries are struggling to cope with the increased mortality and the heavy burden it has inflicted on the European health care systems. Disease of the heart and circulatory system account for 4.30 million deaths each year in Europe and approximately half (48 %) of these deaths are due to Cardio Vascular Death (CVD)

Wed, 19 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M0DF-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=M0DF-01-00-00-00

In this research service the market for computer aided detection is discussed in detailed taking into account the trends, market drivers, restraints and challenges. It also discusses the competitive structure and provides detailed revenue analysis.

Tue, 18 Mar 2008 06:21:05 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124735401 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124735401

At present, cardiovascular diseases are one of the leading causes of premature death with more than 1.5 billion people below the age of 75 losing their lives to it In Europe, annually, about 104.8 billion is being spent on the diagnosis, treatment and rehabilitation of patients with cardiovascular diseases. Faulty lifestyles and the ageing baby boomer population are the main reasons for the rise in incidence of these life-threatening diseases. Under such circumstances, diagnostic cardiac monitoring systems tend to find increasing application in hospitals and cardiac rehabilitation centers to enable effective diagnosis and therapy. Hence, enhanced emphasis on the monitoring of cardiovascular diseases to facilitate prevention and early treatment is expected to propel growth in the European diagnostic cardiac monitoring systems market.

Tue, 18 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736055 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736055

The current estimates place the cost to develop a drug from concept to market at more than $800 million with a rise to as much as $1.7 billion when taking into account pre-launch marketing costs, with a total time period of up to 15 years. The speed at which drug development is expected to bring novel drug targets to the market is challenging not only for small start-up companies but also for large, well-established firms. Issues like unavailability of analytical methods, reagents, relevant animal models, experienced staff and adequate funding, quality of data, regulatory pathway and the management team are all factors contributing to the delay of novel therapies.

Tue, 18 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736402 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736402

As the global population affected by chronic obstructive pulmonary disease (COPD) touches the 600 million mark, vendors pertaining to non invasive ventilation (NIV) equipment are capitalizing on the situation to steer the market towards a healthy growth. In Europe, the condition with regards to the COPD patient population is also getting worse. It is estimated that over 10 per cent of the entire European population suffers from COPD. Furthermore, the patient population pertaining to sleep apnoea is on a rise.

Tue, 18 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736421 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=124736421

Several procedures such as culture techniques, Immunoassays/Serology and Fluorescent In Situ Hybridisation (FISH) have been used to detect disease agents for many years. However amplification technology has shown to be very popular between end users and is creating a great amount of interest in the market place.

Tue, 18 Mar 2008 00:00:00 +0000 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1B6-01-00-00-00 http://www.frost.com/prod/servlet/report-homepage.pag?Src=RSS&repid=N1B6-01-00-00-00

This Research Service analyzes market trends in the United States electronic prescribing markets among ambulatory care providers since 2003, forecasts future changes in market measurements through 2013, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. The U.S e-prescribing markets among ambulatory care providers market was further sub-segmented into the stand alone and integrated physicians practice management systems.

Fri, 14 Mar 2008 09:27:39 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0C-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D950-00-0C-00-00

This week's edition of the Drug Discovery Technology Alert features articles on promising class of anticancer compunds, transdermal microprojection patch for drug delivery, adult stem cell therapies for bone, joint, and cardiovascular diseases, novel small molecule drug for cancer, plant-based protein expression system, protein therapeutic for wound healing, mitochondrial analysis tool kits for studying drug effects and siRNA therapies for ovarian cancer.

Fri, 14 Mar 2008 04:56:38 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6B-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D850-00-6B-00-00

This week's edition of Medical Device Technology Alert features articles on a oral cancer screening technology, an innovative magnetic separation exploiting breast cancer gene sensing device, a biodisplacement assay technology using SERRS, a novel quantum cascade laser chip for medical diagnostic applications, a sensor system for detection of lead and heavy metals, a blind system indentification technique, bioactive cements, and an acupuncture device for pain management.

Fri, 14 Mar 2008 04:50:38 +0000 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-92-00-00 http://www.frost.com/prod/servlet/market-service-segment.pag?Src=RSS&segid=D754-00-92-00-00

GammaCan's therapy using immunoglobulins from donors with vitilgo, a skin disorder, shows promise against melanoma in animal experiments. Biovitrum and Syntonix advance clinical testing of a long-acting recombinant factor IX to treat hemophilia B patients. Zevalin, a monoclonal antibody linked to a cell-killing radioactive isotope, combined with CHOP chemotherapy attains a 100% response rate in elderly patients with diffuse large B-cell lymphoma. Research at Dendreon validates the marker it has been using to measure the potency of its Provenge individualized cell therapy before administering it for prostate cancer treatment. Amgen licenses a monoclonal antibody with potential for treating inflammatory disorders and cancer from Kyowa Hakko.

Fri, 14 Mar 2008 03:44:39 +0000